Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 5—May 2023
Research

Case–Control Study of Long COVID, Sapporo, Japan

Toshiaki Asakura1, Takashi Kimura1Comments to Author , Isaku Kurotori, Katabami Kenichi, Miyuki Hori, Mariko Hosogawa, Masayuki Saijo, Kaori Nakanishi, Hiroyasu Iso, and Akiko Tamakoshi
Author affiliations: Hokkaido University, Sapporo, Japan (T. Asakura, T. Kimura, I. Kurotori, K. Kenichi, A. Tamakoshi); National Center for Global Health and Medicine, Tokyo, Japan (M. Hori, M. Hosogawa, H. Iso); Health and Welfare Bureau, Sapporo (M. Saijo, K. Nakanishi)

Main Article

Figure 3

Percentage of symptoms reported among participants in a case–control study of long COVID, Sapporo, Japan. A) Number of symptoms at designated timepoints from onset among case-patients and among controls at the time of answering the questionnaire. B) Detail of percentage of participants with >2 symptom types. Error bars represent 95% CIs.

Figure 3. Percentage of symptoms reported among participants in a case–control study of long COVID, Sapporo, Japan. A) Number of symptoms at designated timepoints from onset among case-patients and among controls at the time of answering the questionnaire. B) Detail of percentage of participants with >2 symptom types. Error bars represent 95% CIs.

Main Article

1These authors contributed equally to this article.

Page created: March 13, 2023
Page updated: April 18, 2023
Page reviewed: April 18, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external